Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
Cytokinetics Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).
The capital structure exhibits a profound shift from a predominantly equity-funded position to one characterized by significant liability expansion and a substantial stockholders' deficit. Total liabilities as a percentage of total liabilities and stockholders' equity increased from 64.42% in March 2018 to 159.25% by September 2023, indicating a trajectory of increasing financial leverage and a growing reliance on external financing.
- Non-Current Liability Composition
- A structural transformation is evident in the long-term debt profile. Convertible notes, which were absent in early 2018, emerged in December 2019 at 29.05% and grew consistently to become the dominant liability at 74.01% by September 2023. Concurrently, liabilities related to revenue participation right purchase agreements peaked at 73.50% in September 2019 before fluctuating and settling at 49.97% by the end of the period. Term loans, which initially represented a significant portion of the balance sheet (peaking at 23.89% in September 2019), declined and stabilized at approximately 8.22%.
- Equity and Deficit Trends
- Stockholders' equity experienced a severe decline, moving from a positive 35.58% in March 2018 to a deficit of -59.25% by September 2023. This erosion is driven primarily by the accumulated deficit, which expanded from -235.19% to -266.72% over the analyzed period. While additional paid-in capital provided significant offsets—peaking at 434.24% in September 2019—it was insufficient to counter the growing accumulated losses and the increase in total liabilities, leading to a persistent negative equity position starting in early 2023.
- Current Liability Stability
- In contrast to the volatility of long-term obligations, current liabilities remained relatively stable as a percentage of the total balance sheet. Total current liabilities generally fluctuated between 5.82% and 13.77%. Accrued liabilities and accounts payable consistently represented small fractions of the total structure, suggesting that the company's financial instability is rooted in long-term financing and accumulated losses rather than short-term liquidity pressures.
- Operating Lease Obligations
- Long-term operating lease liabilities showed a notable increase in the latter half of the period. After remaining negligible between 2019 and 2020, these liabilities rose to 14.84% in March 2021 and reached 16.50% by September 2023, reflecting an increased proportion of lease-based asset utilization relative to the total capital structure.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?